About
Kumquat Biosciences develops innovative small molecule and immuno-oncology therapies targeting the KRAS pathway to treat cancers with undruggable mutations, aiming to deliver durable therapeutic benefits by combining targeted and immune-based approaches.
Explore Kumquat Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.